Assets of BioLineRx Ltd. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
BioLineRx Ltd. quarterly Assets in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • BioLineRx Ltd. Assets for the quarter ending 31 Dec 2024 was $38,906,000, a 39% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

BioLineRx Ltd. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $38,906,000 -$25,019,000 -39% 31 Dec 2024 20-F 31 Mar 2025 2024 FY
Q2 2024 $64,596,000 +$5,660,000 +9.6% 30 Jun 2024 6-K 15 Aug 2024 2024 Q2
Q4 2023 $63,925,000 -$12,459,000 -16% 31 Dec 2023 20-F 31 Mar 2025 2024 FY
Q2 2023 $58,936,000 -$8,902,000 -13% 30 Jun 2023 6-K 30 Aug 2023 2023 Q2
Q4 2022 $76,384,000 -$5,007,000 -6.2% 31 Dec 2022 20-F/A 26 Mar 2024 2023 FY
Q2 2022 $67,838,000 -$23,491,000 -26% 30 Jun 2022 6-K 16 Aug 2022 2022 Q2
Q4 2021 $81,391,000 +$34,101,000 +72% 31 Dec 2021 20-F 22 Mar 2023 2022 FY
Q2 2021 $91,329,000 +$38,340,000 +72% 30 Jun 2021 6-K 18 Aug 2021 2021 Q2
Q4 2020 $47,290,000 -$6,277,000 -12% 31 Dec 2020 20-F 16 Mar 2022 2021 FY
Q2 2020 $52,989,000 -$8,969,000 -14% 30 Jun 2020 6-K 06 Aug 2020 2020 Q2
Q4 2019 $53,567,000 -$2,666,000 -4.7% 31 Dec 2019 20-F 23 Feb 2021 2020 FY
Q2 2019 $61,958,000 +$9,745,000 +19% 30 Jun 2019 6-K 06 Aug 2019 2019 Q2
Q4 2018 $56,233,000 -$4,732,000 -7.8% 31 Dec 2018 20-F 12 Mar 2020 2019 FY
Q2 2018 $52,213,000 30 Jun 2018 6-K 13 Aug 2018 2018 Q2
Q4 2017 $60,965,000 +$22,026,000 +57% 31 Dec 2017 20-F 28 Mar 2019 2018 FY
Q4 2016 $38,939,000 31 Dec 2016 20-F 06 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.